Date with a Cure 2025 delved into the latest findings on donanemab, lecanemab, and more trials happening right now - along with how proposed budget changes at the federal level impact Alzheimer’s research. Check out the full webinar and a recap of the main points covered.
When it comes to developing Alzheimer’s, there are a number of known risk factors – but how about the air you breathe? Researchers at the University of Southern California have been awarded an $11.5 million grant by the National Institute of Aging to analyze how toxins in the air can accelerate the risk of Alzheimer’s and other forms of dementia.
